"Will seek to increase participation in clinical trials to 10 percent of adult cancer patients by requiring coverage of patient clinical trial costs in the new public and private plans offered through the National Health Insurance Exchange, increasing NCI reimbursement for patient participation in clinical research and requesting the NCI Director to identify regulatory barriers that prevent the timely implementation and completion of successful clinical trials."